Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.56 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 2/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692576 | 1.00 | GGT1 (0.56) | GGT1CPB2CA2CA4CPB1 | |
| SCHEMBL7091886 | 1.00 | GGT1 (0.56) | GGT1CPB2CA2CA4CPB1 | |
| Water SCHEMBL25415254 | 0.98 | GGT1 (0.55) | GGT1CPB2CA2CA4CPB1 | |
| SCHEMBL1446361 | 0.98 | GGT1 (0.55) | GGT1CPB2CA2CA4CPB1 | |
| Ethylenediamine SCHEMBL8741929 | 0.91 | GGT1 (0.47) | GGT1CA2CA4GABRR1LMNA | |
| SCHEMBL30370036 | 0.88 | GGT1 (0.46) | GGT1CPB2CA2CA4MME | |
| SCHEMBL30437177 | 0.88 | GGT1 (0.46) | GGT1CPB2CA2CA4MME | |
| SCHEMBL30436578 | 0.88 | GGT1 (0.46) | GGT1CPB2CA2CA4MME | |
| SCHEMBL30437179 | 0.88 | GGT1 (0.46) | GGT1CPB2CA2CA4MME | |
| SCHEMBL7861449 | 0.88 | GGT1 (0.46) | GGT1CPB2CA2CA4MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2920249-B1 | SELF-DISPERSING PIGMENTS | CHEMOURS CO FC LLC (US) | 2020-04-01 | — | — | EP | claimed |
| US-10316209-B2 | Self-dispersing pigments | THE CHEMOURS COMPANY FC, LLC (US) | 2019-06-11 | — | — | US | claimed |
| CN-104937040-B | Self-dispersing pigment | 纳幕尔杜邦公司 | 2017-11-21 | — | — | CN | claimed |
| CN-104919007-B | Self-dispersing pigments comprising silica | 纳幕尔杜邦公司 | 2017-09-26 | — | — | CN | claimed |
| US-20150307683-A1 | SILICA CONTAINING SELF-DISPERSING PIGMENTS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-29 | — | — | US | claimed |
| US-20150291822-A1 | SELF-DISPERSING PIGMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-15 | — | — | US | claimed |
| CN-104937040-A | Self-dispersing pigments | DU PONT | 2015-09-23 | — | — | CN | claimed |
| CN-104919007-A | Self-dispersing pigments comprising silica | DU PONT | 2015-09-16 | — | — | CN | claimed |
| US-7442788-B2 | Antisense molecules and method of controlling expression of gene function by using the same | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2008-10-28 | — | — | US | claimed |
| US-6872809-B2 | Nucleoside derivatives | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-03-29 | — | — | US | claimed |
| US-20030208050-A1 | Nucleoside derivatives | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-11-06 | — | — | US | claimed |
| US-20030162739-A1 | Antisense molecules and method of controlling expression of gene function by using the same | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-08-28 | — | — | US | claimed |
| EP-1295892-A1 | ANTISENSE MOLECULES AND METHOD OF CONTROLLING EXPRESSION OF GENE FUNCTION BY USING THE SAME | Japan Science and Technology Corporation (JP) | 2003-03-26 | — | — | EP | claimed |
| EP-1295891-A1 | NUCLEOSIDE DERIVATIVES | Japan Science and Technology Corporation (JP) | 2003-03-26 | — | — | EP | claimed |
| CN-116426491-A | Preparation method for synthesizing AMA and derivatives thereof by double enzyme coupling | 中国药科大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-113521272-B | Novel coronavirus pneumonia DNA nano vaccine and preparation method thereof | 四川大学 | 2023-05-09 | — | — | CN | disclosed |
| EP-4160208-A1 | URINE SEDIMENT STAINING LIQUID | TOYOBO CO., LTD. (JP) | 2023-04-05 | — | — | EP | disclosed |
| EP-1165488-A1 | PROCESS FOR THE PREPARATION OF POLYAMINO SUCCINIC ACIDS AND DERIVATIVES THEREOF | THE DOW CHEMICAL COMPANY (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001096355-A1 | NUCLEOSIDE DERIVATIVES | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2001-12-20 | — | — | WO | disclosed |
| WO-2000058263-A1 | PROCESS FOR THE PREPARATION OF POLYAMINO SUCCINIC ACIDS AND DERIVATIVES THEREOF | THE DOW CHEMICAL COMPANY (US) | 2000-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162739-A1 | Antisense molecules and method of controlling expression of gene function by using the same | RNGTT, RNMT, UPF1 | GGT1 2807/4885CPB2 2425/4885CA2 3574/4885 |
| US-20030208050-A1 | Nucleoside derivatives | RIMKLA, MTHFD1, AADAT | GGT1 279/4885CPB2 1928/4885CA2 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.